The Physiotherapy Management of Thalassaemia and Sickle Cell Anaemia: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:


== Thalassaemia ==
== Thalassaemia ==
Thalassaemia is one of the most common inherited diseases worldwide. It is defined as an autosomal recessive blood disorder that results from reduction or abscent in the production of globin chains that make up the haemoglobin (Hb) leading to abnormal destruction of erythrocytes and consequently decreased oxygen delivery.   
Thalassaemia is one of the most common inherited diseases worldwide. It is defined as an autosomal recessive blood disorder that results from reduction or absence in the production of globin chains that make up the haemoglobin (Hb) leading to abnormal destruction of erythrocytes and consequently decreased oxygen delivery<ref>Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harbor perspectives in medicine. 2013 Feb 1;3(2):a011775.</ref>.   


Thalassemia is derived from the Greek word "Thalassa" which means <nowiki>''sea''. It's also referred to as ''Mediterranean Anaemia''</nowiki>. It mainly affects individuals originating from the Mediterranean area, Middle East, Transcaucasia, Central Asia, Indian subcontinent, and Southeast Asia.  
Thalassemia is derived from the Greek word "Thalassa" which means <nowiki>''sea''. It's also referred to as ''Mediterranean Anaemia''</nowiki>. It mainly affects individuals originating from the Mediterranean area, Middle East, Transcaucasia, Central Asia, Indian subcontinent, and Southeast Asia<ref name=":0">Kora A. The Physiotherapy Management of Thalassaemia and Sickle Cell Anaemia. Physioplus Course 2020</ref>.  


commonly found in, but not exclusively to, children with Mediterranean origins
There are two types of Thalassaemia: α- and β- and complex thalassemias depending on the type of the involved globin chain.  The incidence rate is about 4.4 of every 10000 live births globally and approximately about 5% of all population<ref name=":0" />. 


There are two types of Thalassaemia: α- and β- and complex thalassemias depending on the type of the involved globin chain.  The incidence rate is about 4.4 of every 10000 live births globally and approximately about 5% of all population. 
It has been estimated that the globally there are 9million carriers of Thalassaemia and Sickle cell anaemia become pregnant each year<ref>Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008;86:480-7.</ref>.
 
It has been estimated that the globally there are 9million carriers of Thalassaemia and Sickle cell anaemia become pregnant each year<ref>Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008;86:480-7.</ref>.  


== Sickle Cell Anaemia  ==
== Sickle Cell Anaemia  ==

Revision as of 16:22, 30 September 2020

Thalassaemia[edit | edit source]

Thalassaemia is one of the most common inherited diseases worldwide. It is defined as an autosomal recessive blood disorder that results from reduction or absence in the production of globin chains that make up the haemoglobin (Hb) leading to abnormal destruction of erythrocytes and consequently decreased oxygen delivery[1].

Thalassemia is derived from the Greek word "Thalassa" which means ''sea''. It's also referred to as ''Mediterranean Anaemia''. It mainly affects individuals originating from the Mediterranean area, Middle East, Transcaucasia, Central Asia, Indian subcontinent, and Southeast Asia[2].

There are two types of Thalassaemia: α- and β- and complex thalassemias depending on the type of the involved globin chain. The incidence rate is about 4.4 of every 10000 live births globally and approximately about 5% of all population[2].

It has been estimated that the globally there are 9million carriers of Thalassaemia and Sickle cell anaemia become pregnant each year[3].

Sickle Cell Anaemia[edit | edit source]

References[edit | edit source]

  1. Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harbor perspectives in medicine. 2013 Feb 1;3(2):a011775.
  2. 2.0 2.1 Kora A. The Physiotherapy Management of Thalassaemia and Sickle Cell Anaemia. Physioplus Course 2020
  3. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008;86:480-7.